UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

L-type CaV1.2 calcium channels: from in vitro findings to in vivo function

Physiological reviews, 2014-01, Vol.94 (1), p.303-326

2014

Volltextzugriff (PDF)

Diabetesremission durch Gewichtsmanagementprogramme: 5-Jahres-Follow-up der DiRECT-Studie

Diabetologie (Online), 2024, Vol.20 (4), p.592-593

Kahl, Sabine

2024

Volltextzugriff (PDF)

Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance

The Journal of clinical investigation, 2017-02, Vol.127 (2), p.695-708

2017

Volltextzugriff (PDF)

Gewichts(un)abhängige Effekte von Tirzepatid

Diabetologe, 2021-07, Vol.17 (5), p.605-606

Kahl, Sabine

2021

Volltextzugriff (PDF)

Semaglutid zur Behandlung der nichtalkoholischen Steatohepatitis

Diabetologe, 2021-03, Vol.17 (2), p.220-222

Kahl, Sabine

2021

Volltextzugriff (PDF)

Dallas steatosis index“ zur Vorhersage der nichtalkoholischen Fettlebererkrankung

Diabetologe, 2020-12, Vol.16 (8), p.749-750

Kahl, Sabine

2020

Volltextzugriff (PDF)

Natrium-Glukose-Cotransporter-2-Inhibition und Nierenfunktion im klinischen Alltag

Diabetologe, 2020-03, Vol.16 (2), p.192-194

Kahl, Sabine

2020

Volltextzugriff (PDF)

Erratum zu: Frühzeitige Kombinationstherapie bei Typ-2-Diabetes

Diabetologe, 2019-07, Vol.15 (5), p.478-478

Kahl, Sabine

2019

Volltextzugriff (PDF)

Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

The lancet. Diabetes & endocrinology, 2014-05, Vol.2 (5), p.406-416

2014

Volltextzugriff (PDF)

Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes

Diabetes (New York, N.Y.), 2016-07, Vol.65 (7), p.1849-1857

2016

Volltextzugriff (PDF)

Metabolic liver disease in diabetes – From mechanisms to clinical trials

Metabolism, clinical and experimental, 2020-10, Vol.111, p.154299-154299, Article 154299

2020

Volltextzugriff (PDF)

Collider bias in observational studies: consequences for medical research. Part 30 of a series on evaluation of scientific publications

Deutsches Ärzteblatt international, 2022-02

2022

Volltextzugriff (PDF)

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Metabolism, clinical and experimental, 2024-08, Vol.157, p.155937, Article 155937

2024

Volltextzugriff (PDF)

Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis

Seminars in liver disease, 2022-02, Vol.42 (1), p.48

2022

Volltextzugriff (PDF)

Collider Bias in Observational Studies

Deutsches Ärzteblatt international, 2022-02, Vol.119 (7), p.107-122

2022

Volltextzugriff (PDF)

Metabolic surgery-induced changes of the growth hormone system relate to improved adipose tissue function

International Journal of Obesity, 2023-06, Vol.47 (6), p.505-511

2023

Volltextzugriff (PDF)

Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease

Journal of hepatology, 2022-12, Vol.77 (6), p.1504-1514

2022

Volltextzugriff (PDF)

Collider Bias in Observational Studies: Consequences for Medical Research Part 30 of a Series on Evaluation of Scientific Publications

Deutsches Ärzteblatt international, 2022-02, Vol.119 (7), p.107-112

2022

Volltextzugriff (PDF)

Different effects of bariatric surgery on epigenetic plasticity in skeletal muscle of individuals with and without type 2 diabetes

Diabetes & metabolism, 2024-09, Vol.50 (5), p.101561, Article 101561

2024

Volltextzugriff (PDF)

Novel markers and networks related to restored skeletal muscle transcriptome after bariatric surgery

Obesity (Silver Spring, Md.), 2024-02, Vol.32 (2), p.363-375

2024

Volltextzugriff (PDF)

Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease

Metabolism, clinical and experimental, 2024-02, Vol.151, p.155762-155762, Article 155762

2024

Volltextzugriff (PDF)

1212-P: Adipose Tissue Mitochondrial Function in Humans with Varying Liver Histology

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

NASH patient’s itinerary: Comparison of strategies for screening, referring and management

Journal of hepatology, 2022-07, Vol.77, p.S451

2022

Volltextzugriff (PDF)

Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)

Diabetes care, 2014-08, Vol.37 (8), p.2326-2333

2014

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

ThemaDiabetes Mellitus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(87)
Deutsch
(30)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

L-type CaV1.2 calcium channels: from in vitro findings to in vivo function

Diabetesremission durch Gewichtsmanagementprogramme: 5-Jahres-Follow-up der DiRECT-Studie

Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance

Gewichts(un)abhängige Effekte von Tirzepatid

Semaglutid zur Behandlung der nichtalkoholischen Steatohepatitis

Dallas steatosis index“ zur Vorhersage der nichtalkoholischen Fettlebererkrankung

Natrium-Glukose-Cotransporter-2-Inhibition und Nierenfunktion im klinischen Alltag

Erratum zu: Frühzeitige Kombinationstherapie bei Typ-2-Diabetes

Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes

Metabolic liver disease in diabetes – From mechanisms to clinical trials

Collider bias in observational studies: consequences for medical research. Part 30 of a series on evaluation of scientific publications

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis

Collider Bias in Observational Studies

Metabolic surgery-induced changes of the growth hormone system relate to improved adipose tissue function

Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease

Collider Bias in Observational Studies: Consequences for Medical Research Part 30 of a Series on Evaluation of Scientific Publications

Different effects of bariatric surgery on epigenetic plasticity in skeletal muscle of individuals with and without type 2 diabetes

Novel markers and networks related to restored skeletal muscle transcriptome after bariatric surgery

Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease

1212-P: Adipose Tissue Mitochondrial Function in Humans with Varying Liver Histology

WED-195 NASH-PI: a randomized trial to compare cost-effectiveness across strategies for screening, referring and management of MASLD patients in clinical practice

NASH patient’s itinerary: Comparison of strategies for screening, referring and management

Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)

Aktive Filter

Suchergebnisse filtern